Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study – Reuters By Weight Loss Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study Reuters Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest